MYC and lymphoma: Tumorigenesis was not significantly retarded in mice homozygous for the vavP-MYC10 transgene or in another T lymphoma-susceptible line (vavP-MYC17), possibly because Mnt heterozygosity is insufficient to counter the higher levels of Myc in these strains.